FIRST-ENGOT-OV44 phase III trial

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

December, 2024

FIRST-ENGOT-OV44 phase III trial

Dec 22, 2024, 16:56 | Insight

GSK Announced Landmark Results from FIRST Trial in First-Line Advanced Ovarian Cancer

GSK has announced that the FIRST-ENGOT-OV44 phase III trial evaluating the combination of Zejula (niraparib)…

All: 1 Posts: 1 - 100

'

New Paper Alert! HR+ Breast Cancer: Efficacy of Subsequent Treatments After CDK4/6 Inhibitor Progression

'

Carlos Rodriguez-Galindo: The Man Who Will Cure the World

'

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

'

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

'

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023